Context: Recent large-scale genome-wide association studies identified novel genetic variants associated with obesity and body mass index (BMI) in addition to the well-described FTO and MC4R genetic variants.
activity in recent decades. This obesity epidemic is affecting both developed and developing countries, such as China. Based on the World Health Organization recommended obesity criteria for Asians (2) , the prevalence of obesity [body mass index (BMI) Ն27.5kg/m 2 ] in men was 10.5% in mainland China (3) , whereas that in the Hong Kong Chinese population was higher, being about 16.3% (4) , according to the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS).
Obesity is a multifactorial condition resulting from the complex interaction between environmental and genetic factors (1, 5) . Twins and adoption studies have demonstrated clear evidence for the genetic predisposition to the development of obesity (6, 7) . Recently two large-scale genome-wide association (GWA) studies by Thorleifsson et al. (8) and Willer et al. (9) identified a number of novel genetic variants associated with obesity and/or BMI. These included variants at or close to 13 genetic loci: KCTD15 , as well as the well-described FTO (fat mass and obesity associated) (10 -12) and MC4R (melanocortin 4 receptor) (13, 14) loci. A recent replication study in the Swedish population reported significant association with obesity in variants at or close to FTO, SH2B1, MTCH2, MC4R, NEGR1, and GNPDA2 (15) . It should be noted that these studies were conducted mainly on subjects from Caucasian ancestry. Successful replications of the novel association signals in different populations will be important for the validation of these novel findings. Several casecontrol and population-based studies had shown significant associations of the well-known FTO variants (rs8050136 and rs9939609) with obesity and BMI in Hong Kong, Taiwan, and Singapore Chinese populations (16 -18) . Contrarily, Li et al. (19) reported no association of the FTO variants with obesity and BMI in a populationbased cohort of Shanghai and Beijing Chinese, and a multiethnic study also described lack of association of rs9939609 with waist circumference (WC) or severe obesity in a Chinese subgroup (20) . However, apart from the FTO variants, little is known about the implications of the other genetic variants discovered in recent GWA studies in Chinese. Our objective was to examine these previously reported obesity and/or BMI-associated loci for associations with obesity in a case-control study of Chinese subjects.
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Subjects and Methods
Case-control study
We performed a cross-sectional case-control study involving 1170 Chinese subjects to examine the association with obesity in 13 single-nucleotide polymorphisms (SNPs), each of which would represent one of the genetic loci that were previously reported to have an association with obesity and/or BMI in Caucasians (8, 9) . Subjects with BMI of 27.5kg/m 2 or greater were considered obese, according to the recommendation for Asians (2) . Unrelated obese subjects (n ϭ 470) with BMI of 27.5kg/m 2 or greater were either selected, on the basis of their BMI, from the CRISPS cohort, which has been described elsewhere (21) (22) (23) , or were recruited from the Endocrine Clinic at the Queen Mary Hospital, Hong Kong, whereby secondary causes of obesity had been excluded. Unrelated healthy lean controls (n ϭ 700) were all selected from the CRISPS cohort and had normal BMI defined as 18.5-23 kg/m 2 (2). In addition, 23.6% of the cases and 3.1% of the normal-weight controls had T2DM. There was no significant difference in age or sex distribution between the two groups ( Table 1) .
The extension study included a total of 1938 subjects (46.44% male; mean age 45.97 Ϯ 12.21 yr) from the populationbased CRISPS cohort with available DNA samples. Of these, 957 (ϳ49%) were already included in the case-control study on the basis of their BMI.
Anthropometric and biochemical measurements
The anthropometric (including weight, height, BMI, and WC) and biochemical measurements (including plasma glucose and plasma insulin) were measured as previously described (21- b Log transformed before analysis.
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). All participants were studied after written informed consent, and the study protocol was approved by the Ethics Committee of the University of Hong Kong.
Genetic analyses
SNPs located in the 13 genetic loci identified through the recent GWA studies showing significant associations with obesity and/or BMI (8, 9) were examined for association with obesity in the present study. For the reported SNPs showing strong linkage disequilibrium (LD) (r 2 Ͼ 0.8) on the HapMap for Han Chinese (25), only one representative SNP was chosen for genotyping, and for loci with more than one reported association SNPs, the SNP with the strongest association in the previous report was selected to represent the locus. A total of 13 SNPs was thus selected, and these included rs3101336 (NEGR1, r 2 ϭ 1 with rs2568958 and rs2815752), rs10913469 (SEC16B-RASAL2), rs4854344 (TMEM, r 2 ϭ 1 with rs7561317 and rs6548238), rs7647305 (SFRS10-ETV5-DGKG), rs10938397 (GNPDA2), rs2844479 (NCR3-AIF1-BAT2), rs925946 (LGR4-LIN7C-BDNF), rs10838738 (MTCH2), rs7138803 (BCDIN3D-FAIM2), rs4788102 (SH2B1-ATP2A1, r 2 ϭ 1 with rs7498665), rs8050136 (FTO, rs8050136 r 2 ϭ 1 with rs9939609), rs17782313 (MC4R, r 2 ϭ 0.81 with rs12970134), and rs29941 (KCTD15). Genomic DNA was extracted from buffy coat by the standard phenol-chloroform extraction procedures. All SNPs were genotyped by the Sequenom iPLEX Gold genotyping assay, except rs10938397, rs2844479, and rs29941. Genotyping for these three SNPs were performed using TaqMan predesigned SNP genotyping assay (rs10938397: assay ID: C_1594245_10; rs2844479: assay ID: C_26778727_10; rs29941: assay ID: C_2843134_10; Applied Biosystems, Foster City, CA). PCRs were performed in the GeneAmp PCR System 9700 thermal cycler according to the manufacturer's protocols, and assay products were analyzed using Applied Biosystems PRISM 7000 sequence detection system for fluorescence intensity detection. At least two negative controls (without DNA) were included for the identification of contaminations in each 96-well plate. Hardy-Weinberg equilibrium for each SNP was examined by the exact test using PLINK (26) . Hardy-Weinberg equilibrium P values were greater than 0.05 in the case and control subjects for all SNPs. Average successful genotyping call rate in the case-control study was 99.23% and concordant rate was 99.6%, based on 20 duplicate samples. Average successful genotyping call rate and concordant rate in the extension study of the three SNPs were greater than99.24%.
Statistical analysis
All statistical analyses were performed with either PLINK version 1.05 (available at http://pngu.mgh.harvard.edu/ϳpurcell/ plink/) (26) or SPSS (version 16.0; Chicago, IL). All continuous variables were expressed as mean Ϯ SD or median with interquartile range as appropriate. To correct for multiple comparisons, Bonferroni corrections and false discovery rate (FDR) analyses were performed. All variables that did not follow a normal distribution, as shown by a significant P value in the Kolmogorov-Simirnov test, were natural-logarithmically transformed before analysis. 2 tests, logistic regressions, and linear regressions under the additive model implemented in PLINK were used to estimate the associations of each SNP with obesity and its related phenotypic parameters. We reported one-tailed P values calculated on the basis of the direction of effects presented in the original GWA studies reports. If an odds ratio (OR) was in the same direction as previously reported, a one-tailed P value was calculated as P divided by 2 (P/2), whereas a one-tailed P value for an opposite effect was calculated as 1 minus P divided by 2 (1-P/2). A one-tailed P Ͻ 0.05 was considered as statistically significant.
To compare the effects of SNPs in this study and those in the original GWA reports, a pooled OR was reported in Table 2 for SNPs that were studied in both of the GWA reports. The logged OR from each of the GWA studies were combined and inversely weighted by their variances. This produced a pooled logged OR and its sampling variance, which were then converted into a pooled OR with its 95% confidence interval (CI). The statistical power of the study was calculated using the Genetic Power Calculator (available at http://pngu.mgh.harvard.edu/ϳpurcell/ gpc/) (27) .
Combined genetic risk scores (GRSs) for the 13 SNPs studied were calculated by four different methods as previously described (28): 1) simple count (count GRS); 2) weighted GRS, based on published ORs; 3) weighted GRS, based on ORs of the current study; and 4) weighted GRS developed by multiple logistic regression analysis of the current data. For comparison with the count GRS, each score derived from methods 2-4 was divided by the corresponding maximum possible score and then multiplied by 26. The GRS derived from each of these methods was analyzed by logistic regression as a continuous predictor variable. Subjects (36 cases and 48 controls) with missing genotypes for any of the 13 SNPs were excluded from analyses of the combined genetic risk. The receiver-operating characteristic (ROC) curves were plotted with the corresponding area under the curve (AUC) calculated in SPSS (version 16.0).
Results
Association with obesity in case-control study
We genotyped 13 SNPs from the 13 loci that showed significant associations with obesity and/or BMI in the recent GWA studies (8, 9) in 470 obese subjects (BMI Ն27.5) and 700 normal-weight individuals (18.5 Յ BMI Յ 23.0) of Chinese ancestry. Their clinical characteristics were shown in Table 1 . Table 2 shows the results of the association analyses of the 13 SNPs with obesity and the effect allele frequencies. The allele frequencies of SNPs observed in the current study (Table 2) were similar to those reported in the HapMap Han Chinese. In our case-control cohort, seven of the 13 SNPs showed statistically significant associations with obesity. These included the GNPDA2 SNP rs10938397 [one tailed P ϭ 7.3 ϫ 10
Ϫ4
; OR (95% CI) To account for multiple testing, FDR analyses and Bonferroni correction were performed. All seven SNPs were significant at FDR ϭ 0.1, four SNPs (rs10938397, rs8050136, rs17782313, and rs29941) were significant at a more stringent criteria of FDR ϭ 0.05. The GNPDA2, FTO, and MC4R SNPs, rs10938397, rs8050136, and rs17782313, showed the most significant associations and remained significant, even after Bonferroni correction for multiple testing. Figure 1 shows the ORs and 95% CI for association with obesity for the 13 SNPs and the published ORs for each SNP as reported from the GWA studies. As shown, the ORs of the SNPs in this study were comparable with those detected in the GWA studies, with the latter ORs all being within 95% CI of the ORs observed in this study. Moreover, we observed an excess of SNPs with small P values compared with expectation of no association, indicating that at least some of the observed associations with obesity in this study are true (Fig. 2) . Figure 3 shows the frequency distribution of the number of risk alleles of the 13 SNPs in the case and control groups. The highest number of risk alleles observed in any subject was 17; individuals with number of risk alleles of six or less (3.8%), or 14 or more (3.3%), were grouped because of their low frequencies. From logistic regression analysis, the count GRS showed an OR of 1. current data set, and ORs derived from multiple logistic regression, respectively. In the ROC analysis, the AUC was 0.582 for the simple count method, and 0.592, 0.614, and 0.617 for the three weighted GRSs, respectively. Supplemental Fig. 1 ; AUC 0.617) for the weighted GRS based on the ORs of the current study and multiple logistic regression, respectively.
Combined genetic risk of obesity
Association with BMI in the case-control study
We then further examined the associations of these seven obesity-associated SNPs with the obesity-related quantitative traits including BMI, WC, fasting glucose level, 2-h post-oral glucose tolerance test (OGTT) glucose level, homeostasis model assessment insulin resistance index, and fasting insulin level in case and control groups separately. Supplemental Tables 1 and 2 
Association with BMI and WC in the extension study
Because the associations of rs8050136, rs10938397, and rs17782313 with obesity were highly significant and remained significant, even after Bonferroni correction, we suspected that the lack of association of rs10938397 and rs17782313 with BMI or WC in the case or control groups might have been due to the narrow range of BMI and WC in each respective group. We therefore extended the study of these three SNPs to include the rest of the population in the CRISPS cohort with available DNA samples. Supplemental Table S3 summarizes the results of the association analyses with BMI and WC in the extended study. In a total of 1938 subjects of the CRISPS cohort, we observed significant associations of rs10938397 [one tailed P ϭ 0.011, ␤ (95% CI) 0.29 (0.04, 0.54)], rs17782313 (one tailed P ϭ 0.011, ␤ (95% CI) 0.37 (0.05, 0.68)], and rs8050136 (one tailed P ϭ 7 ϫ 10
Ϫ3
; ␤ (95% CI) 0.42 (0.08,0.75)] with BMI. Similar results were obtained after age and sex adjustment. We also observed, in females, significant associations with WC (rs10938397: one tailed P ϭ 1.5 ϫ 10 Ϫ3 ; ␤ (95% CI) 1.25 (0.41, 2.09); rs17782313: one tailed P ϭ 2 ϫ 10
; ␤ (95% CI) 1.59 (0.52,2.65); rs8050136: one tailed P ϭ 0.010; ␤ (95% CI) 1.36 (0.22,2.49)].
Discussion
In this study, we investigated the associations of 13 previously reported obesity-and/or BMI-associated SNPs with obesity and obesity-related traits in a case-control study involving 1170 Chinese subjects. We successfully replicated the associations with obesity in 7 SNPs in our population. This demonstrated that some of the published obesity-associated genetic variants based on studies in the 
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Caucasian population also impact the development of obesity in this Chinese population. For all seven obesityassociated SNPs, we observed even higher ORs than that reported in the original GWA reports (8, 9) . However, we also noticed that the P values observed for the seven obesity-associated SNPs were less significant than those reported in the original studies, likely to be due to our small sample size (supplemental Table S4 ). Notably, all reported ORs from the GWA studies were contained within the 95% CI in this study (Fig. 1) , suggesting that the unsuccessful replication of the other reported SNPs could have been due to the wide 95% CI and small sample size of this study. Alternatively, it might be due to differences in the genetic compositions and LD patterns between Chinese and Caucasian populations. Indeed, these SNPs tend to be less common in the Chinese population than the Caucasian population (supplemental Table S5 ). Based on the ORs observed in this study, our sample size had a greater than 80% power to detect a significant association of the top three SNPs (98% for rs8050136; 97% for rs10938397 and rs17782313), although the expected power would be 29 -62% for these three SNPs if based on the published effect sizes (supplemental Table S5 ). We showed that the combination of genetic data from the 13 SNPs might provide some meaningful information for predicting the risk of obesity. Nonetheless, the clinical use of such information remains to be established. Approximately 17-23% increased risk of obesity was observed for every unit increase in the combined GRSs. However, the discriminatory power of their genetic risk alleles is likely to be limited, as reflected by the modest magnitude of the AUCs in the ROC analyses. In time, with more and more obesity susceptibility genes being identified, their combined genetic information might become useful for clinical applications, such as in the genetic screening of at-risk individuals.
Despite the fact that we observed significant associations between respective SNPs with obesity, we failed to show an association of these SNPs with the common obesity-related phenotypes, BMI and WC, in our case-control study except for the FTO SNP rs8050136, which was significantly associated with BMI in the case group. This again could have been due to the relatively small sample size and narrow range of the tested quantitative traits in both the case and control groups. In our study, the robust effect of the FTO variant rs8050136 was clearly evident, being the SNP with the highest OR (1.48) for association with obesity and demonstrating significant association with BMI in the case group despite the relatively small sample size and the narrow range of BMI. It has been shown that the estimated heritability of BMI in Chinese ranged from 0.42 to 0.54 (29 -31) . However, based on linear regression analysis, only about 4.1% of this could be explained by the seven obesity-associated SNPs reported in the current study.
When the entire population-based CRISPS cohort was included, significant associations with BMI and WC were observed for rs10938397, rs17782313, and rs8050136. However, we should acknowledge that there were overlapping subjects (ϳ49% of the CRISPS cohort) between the case-control and population-based cohort, and observation of significant associations of these three SNPs with BMI and WC in the CRISPS cohort might be just a reflection of an expanded case-control study. Another large independent Chinese population-based cohort would better enable us to validate our current findings and investigate the associations of these obesity-associated SNPs with obesity-related quantitative traits.
Because the identification of FTO as the important obesity predisposing gene, variants within this gene were extensively studied in different populations (10 -12, 16 -20, 32-34) . rs8050136 and rs9939609, which are in complete LD in the Han Chinese population, are located within a LD block in the first intron of FTO. Various reports described significant associations of the FTO genetic variants within this well-defined LD block with obesity, BMI, WC, and weight (10 -12, 16 -18, 32-34) . In addition to the well-described FTO SNP (rs8050136), the GNPDA2 (rs10938397) and MC4R (rs17782313) SNPs showed the most promising results in this study. rs10938397 is located about 450 kb upstream of GNPDA2 (glucosamine-6-phosphate deaminase 2), which has been proposed to be involved in aminosugar metabolism and carbohydrates metabolisms (35) . rs17782313 is located about 190kb downstream of MC4R: this SNP was previously reported to be associated with obesity, fat mass, weight, and height (13) . rs12970134, a SNP in strong LD with rs17782313 in Han Chinese, was also reported to be associated with WC and insulin resistance (14) . A search for possible transcription factor binding sites using MatInspector (36) suggested that the risk alleles of rs10938397 (G allele) and rs17782313 (C allele) may abolish binding sites for transcription factors MYT1 (myelin transcription factor 1) and ATF4 (activating transcription factor 4), respectively. MYT1, also known as proteolipid protein binding protein, is a zinc finger transcription factor that is involved in neuronal cells development. Myt1 is expressed in both endocrine progenitor and differentiated endocrine cells in embryonic pancreas (37) . Pancreas-specific Myt1 knockout mice showed abnormal endocrine differentiation, glucose intolerance, and attenuated glucose-induced insulin secretion, suggesting a role of Myt1 in regulating differentiation and function of the endocrine pancreas (37) . ATF4 is also known as cAMP-response element-binding protein-2, and it may act as a repressor of cAMP-response element-dependent transcription (38) . Future works elucidating the roles of these putative obesity-related genes and genetic variants will, no doubt, be of great interest.
Obesity is an important risk factor for hyperglycemia and T2DM, and the relationship of obesity-associated SNPs to glycemia deserves attention. Here we observed significant association of rs29941 with fasting plasma glucose level, and this SNP also showed a marginal association with 2-h post-OGTT glucose level in the control group, even after adjustment for age, sex, and BMI. rs29941 is located about 4.4kb downstream of KCTD15 (potassium channel tetramerization domain containing 15). The exact function of KCTD15 is currently unknown, although study of sequence homology comparisons has suggested that it may act as a transcription factor (39, 40) . Further investigation of this gene should be conducted to examine the impact of this gene in the development of T2DM.
In conclusion, we have replicated the associations of seven SNPs with obesity in the Chinese population. We also showed significant associations of the FTO SNP rs8050136 with BMI in the case group and rs29941 located close to KCTD15 with fasting plasma glucose in the control group, even after adjustment for age, sex, and BMI. We showed that the combined genetic risk of SNPs might provide useful information for the prediction of obesity. More positive association signals will continuously emerge through GWA studies in the future, and large-scale independent replication studies from different populations are essential for the verification of these novel association signals. Collaborations between different research groups will be extremely useful in creating a sufficiently large cohort for the detection of variants with modest effect size. Further functional studies to investigate the possible roles of the newly identified obesity-associated genes and fine-mapping studies to identify the causative disease-susceptibility genetic variants will be important to expand our knowledge and understanding of energy homeostasis and the development of obesity.
